DYRK2 mRNA and protein levels are reduced in tissue samples from patients with non-Hodgkin’s lymphoma (NHL), and low DYRK2 expression is associated with poor prognosis in patients with NHL [14]. This evidence concerns the gene DYRK2 and non-Hodgkin lymphoma.